https://www.credenceresearch.com/news/deutsche-telekom-expands-munich-ai-factory-20-mw-nvidia-b300 Credence Research en 2026-11-10T15:09:27.000Z Deutsche Telekom expands Munich AI factory to 20 MW with NVIDIA B300 GPUs https://www.credenceresearch.com/news/siemens-acquire-lauterbach-trace32-eda-chip-verification Credence Research en 2026-11-10T13:03:06.000Z Siemens to Acquire Lauterbach, Adding TRACE32 Debug and Trace Tools to Its Chip Design Portfolio https://www.credenceresearch.com/news/fda-requires-naion-eye-risk-warning-all-glp-1-drugs-ozempic-wegovy-zepbound Credence Research en 2026-11-10T11:16:52.000Z FDA Requires NAION Eye Risk Warning on All GLP-1 Drugs, Including Ozempic, Wegovy and Zepbound https://www.credenceresearch.com/news/qatarenergy-acquire-25-percent-chevron-pel-82-walvis-basin-namibia Credence Research en 2026-11-10T09:02:10.000Z QatarEnergy to Acquire 25% Stake in Chevron-Operated PEL 82 Exploration License Offshore Namibia https://www.credenceresearch.com/news/infineon-first-300mm-silicon-carbide-power-devices-villach Credence Research en 2026-11-10T07:04:20.000Z Infineon Makes First Power Devices on 300 mm Silicon Carbide Wafers in Volume Fab https://www.credenceresearch.com/news/kps-capital-partners-acquire-mm-packaging-mayr-melnhof-2-4-billion-euros Credence Research en 2026-11-10T04:59:25.000Z KPS to Buy 70% of MM Packaging From Mayr-Melnhof at 2.4 Billion Euro Enterprise Value https://www.credenceresearch.com/news/nrc-construction-permit-dow-x-energy-xe-100-long-mott-seadrift-texas Credence Research en 2026-11-10T02:54:26.000Z NRC Approves Construction Permit for Dow and X-energy's Four-Reactor Xe-100 Plant in Texas https://www.credenceresearch.com/news/fda-approves-bayer-sunharbo-asundexian-first-factor-xia-inhibitor-stroke Credence Research en 2026-11-10T00:53:46.000Z FDA Approves Bayer's Sunharbo, First Factor XIa Inhibitor, to Cut Risk of Repeat Stroke https://www.credenceresearch.com/news/honda-3-billion-ohio-auto-plant-hybrid-production-240000-vehicles-2029 Credence Research en 2026-11-09T18:53:36.000Z Honda to Build $3 Billion Ohio Auto Plant, Expand Hybrid Output Across North America https://www.credenceresearch.com/news/nvidia-rebellions-sk-telecom-nvlink-fusion-r200-npu-sovereign-ai Credence Research en 2026-11-09T16:55:08.000Z NVIDIA, Rebellions and SK Telecom to Pair Korean NPUs With NVIDIA GPUs via NVLink Fusion https://www.credenceresearch.com/news/bmw-samsung-sdi-lg-energy-solution-gen6-battery-cell-suppliers Credence Research en 2026-11-09T15:05:12.000Z BMW Adds Samsung SDI and LG Energy Solution as Gen6 Battery Cell Suppliers for Europe and U.S. https://www.credenceresearch.com/news/nrg-energy-sell-six-gas-plants-4-9-gw-ls-power-4-billion Credence Research en 2026-11-09T12:56:47.000Z NRG to Sell Six Gas Plants Totaling 4.9 GW to LS Power for $4 Billion https://www.credenceresearch.com/news/argenx-acquire-unnatural-products-1-15-billion-oral-macrocyclic-peptides Credence Research en 2026-11-09T11:00:34.000Z argenx to Acquire Unnatural Products for Up to $1.15 Billion to Add Oral Macrocyclic Peptides https://www.credenceresearch.com/news/strathcona-resources-acquire-greenfire-resources-2-9-billion-oil-sands-sagd Credence Research en 2026-11-09T09:00:16.000Z Strathcona Resources to Acquire Greenfire in C$2.9 Billion Oil Sands Consolidation Deal https://www.credenceresearch.com/news/cnh-sell-70-percent-construction-equipment-business-kobelco-1-billion-joint-venture Credence Research en 2026-11-09T06:54:42.000Z CNH to sell 70% of construction equipment business to Kobelco in $1 billion joint venture https://www.credenceresearch.com/news/mitsui-chemicals-acquire-jsr-1-84-trillion-yen-photoresist-dbj Credence Research en 2026-11-09T05:17:30.000Z Mitsui Chemicals to Buy Photoresist Maker JSR for 1.84 Trillion Yen With DBJ https://www.credenceresearch.com/news/onsemi-cancels-2-billion-silicon-carbide-expansion-roznov-czech-republic Credence Research en 2026-11-09T03:27:02.000Z Onsemi Scraps Up to $2 Billion Silicon Carbide Expansion at Czech Rožnov Site https://www.credenceresearch.com/news/novartis-pelacarsen-lp-a-horizon-full-results-aha-2026-no-cardiovascular-benefit Credence Research en 2026-11-09T00:56:06.000Z Novartis Halts Pelacarsen Heart Program as Full Lp(a)HORIZON Data Show No Cardiovascular Benefit